Therefore, strategies that can improve the mitochondrial structure and function, overcome the negative effect of TGF-β on the oxygen consumption rate, and promote tubular epithelial cell differentiation are postulated as potent therapeutics for kidney fibrosis in CKD [212,215]. This evidence concerns the gene TGFB1 and chronic kidney disease.